Detalles de la búsqueda
1.
Increasing scientific standards, independence and transparency in post-authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.
Pharmacoepidemiol Drug Saf
; 21(7): 690-696, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22522622
2.
European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.
Pharmacoepidemiol Drug Saf
; 20(10): 1021-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22039593
3.
The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac.
Pharmacoepidemiol Drug Saf
; 23(4): 431-4, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24616204
4.
Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports.
Paediatr Drugs
; 18(1): 55-63, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597489
5.
Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
Paediatr Drugs
; 16(4): 309-19, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24898717
6.
Breastfeeding and overweight: longitudinal analysis in an Australian birth cohort.
J Pediatr
; 147(1): 56-61, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16027696
7.
Indicators of fetal growth do not independently predict blood pressure in 8-year-old Australians: a prospective cohort study.
Hypertension
; 43(2): 208-13, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14718353
Resultados
1 -
7
de 7
1
Próxima >
>>